Related Experiment Video
Updated: Jun 9, 2025

10:10
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
1.4K
Secondary Angle Closure Glaucoma in Weill-Marchesani Syndrome
Valeria Coviltir1,2, Miruna Gabriela Burcel3,4, Maria Cristina Marinescu5
1Ophthalmology Discipline, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Diagnostics (Basel, Switzerland)
|October 25, 2024
Summary
Weill-Marchesani syndrome can cause severe vision loss due to high intraocular pressure. Prompt surgical intervention, including lens extraction and glaucoma surgery, can restore vision and prevent blindness.
Area of Science:
- Ophthalmology
- Genetics
- Cardiology
Background:
- Weill-Marchesani syndrome is a rare genetic disorder characterized by a distinct set of physical features.
- Ophthalmological manifestations, particularly glaucoma, are a significant concern in Weill-Marchesani syndrome.
- Early diagnosis and management are crucial to prevent irreversible vision loss.
Purpose of the Study:
- To report a case of a 16-year-old girl diagnosed with Weill-Marchesani syndrome.
- To describe the ophthalmological findings and surgical management of this condition.
- To emphasize the importance of recognizing Weill-Marchesani syndrome for timely intervention.
Main Methods:
- Case report of a 16-year-old female with decreased visual acuity and elevated intraocular pressure.
- Ophthalmological examination including visual acuity, intraocular pressure, and gonioscopy.
- Surgical intervention involving lens extraction, capsular tension ring, intraocular lens, and Shunt ExPress implantation.
Main Results:
- The patient presented with best-corrected visual acuity of 0.3 (R.E.) and 0.4 (L.E.) and intraocular pressure of 46 mmHg (R.E.) and 42 mmHg (L.E.).
- Post-surgery, best-corrected visual acuity improved to 0.7 (R.E.) and 0.63 (L.E.), and intraocular pressure normalized to 14 mmHg (R.E.) and 13 mmHg (L.E.) at 6 months.
- The patient's ocular and systemic history was consistent with Weill-Marchesani syndrome.
Conclusions:
- Weill-Marchesani syndrome requires a multidisciplinary approach due to its complex systemic and ocular manifestations.
- Glaucoma is a sight-threatening complication of Weill-Marchesani syndrome, necessitating prompt surgical management.
- A high index of suspicion for Weill-Marchesani syndrome is essential in patients presenting with characteristic ocular findings.
Related Concept Videos
Angle Closure Glaucoma: Treatment
441
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
441
Glaucoma: Overview
516
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
516
Open Angle Glaucoma: Treatment
397
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
397

